Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berthezene, Y.
Right arrow Articles by Brasch, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berthezene, Y.
Right arrow Articles by Brasch, R. C.

Radiology, Vol 185, 97-103, Copyright © 1992 by Radiological Society of North America

ARTICLES

Differentiation of alveolitis and pulmonary fibrosis with a macromolecular MR imaging contrast agent

Y Berthezene, V Vexler, R Kuwatsuru, W Rosenau, A Muhler, O Clement, DC Price and RC Brasch
Department of Radiology, University of California, San Francisco 94143- 0628.

The ability of macromolecular contrast agent (polylysine-[gadopentetate dimeglumine]) to allow differentiation of pulmonary fibrosis and alveolitis at magnetic resonance imaging was investigated. Lung damage was induced by means of left bronchial instillation of 200 micrograms of cadmium chloride. Rats were imaged 3 hours (early alveolitic stage, n = 5), 24 hours (late alveolitic stage, n = 5), and 8 days (fibrotic stage, n = 5) later. Rats imaged 3 hours after cadmium chloride instillation demonstrated a gradually increasing contrast enhancement over 45 minutes (from 314% +/- 110 to 476% +/- 69 over baseline [P less than .01]), indicating a leak of paramagnetic macromolecules from the intravascular into the extravascular spaces. Conversely, lung enhancement remained virtually constant after injection of contrast material in contralateral control lungs and in damaged lungs imaged 24 hours and 8 days after cadmium chloride instillation. Furthermore, the enhancement in the fibrotic lung was lower (170% +/- 50) than that in the alveolitic and control lungs (320% +/- 65 and 298% +/- 61, respectively), indicating a decrease in plasma volume in the fibrotic lung. A macromolecular contrast agent can facilitate the differentiation between the exudative and fibrotic phases of interstitial lung disease.


This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
C. A Yi, K. S. Lee, J. Han, M. P. Chung, M. J. Chung, and K. M. Shin
3-T MRI for Differentiating Inflammation- and Fibrosis-Predominant Lesions of Usual and Nonspecific Interstitial Pneumonia: Comparison Study with Pathologic Correlation
Am. J. Roentgenol., April 1, 2008; 190(4): 878 - 885.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Gaeta, A. Blandino, E. Scribano, F. Minutoli, M. Barone, F. Ando, and I. Pandolfo
Chronic Infiltrative Lung Diseases: Value of Gadolinium-Enhanced MRI in the Evaluation of Disease Activity--Early Report
Chest, April 1, 2000; 117(4): 1173 - 1178.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1992 by the Radiological Society of North America.